Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | 5-hydroxytryptamine receptor 2B | ||
Ligand | BDBM50314615 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_625299 (CHEMBL1109737) | ||
EC50 | >10000±n/a nM | ||
Citation | Liu, KK; Lefker, BA; Dombroski, MA; Chiang, P; Cornelius, P; Patterson, TA; Zeng, Y; Santucci, S; Tomlinson, E; Gibbons, CP; Marala, R; Brown, JA; Kong, JX; Lee, E; Werner, W; Wenzel, Z; Giragossian, C; Chen, H; Coffey, SB Orally active and brain permeable proline amides as highly selective 5HT2c agonists for the treatment of obesity. Bioorg Med Chem Lett20:2365-9 (2010) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
5-hydroxytryptamine receptor 2B | |||
Name: | 5-hydroxytryptamine receptor 2B | ||
Synonyms: | 5-HT-2B | 5-HT2B | 5-hydroxytryptamine (serotonin) receptor 2B [Homo sapiens] | 5-hydroxytryptamine receptor 2B (5-HT2B) | 5-hydroxytryptamine receptor 2C (5HT2C) | 5HT2B_HUMAN | HTR2B | Serotonin (5-HT3) receptor | Serotonin 2b (5-HT2b) receptor | Serotonin Receptor 2B | ||
Type: | G Protein-Coupled Receptor (GPCR) | ||
Mol. Mass.: | 54312.47 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Receptor binding assays were performed using human clone stably expressed in CHO cells. | ||
Residue: | 481 | ||
Sequence: |
| ||
BDBM50314615 | |||
n/a | |||
Name | BDBM50314615 | ||
Synonyms: | (S)-N-(3,5-difluoro-4-((1s,4s)-4-methylcyclohexyloxy)benzyl)pyrrolidine-2-carboxamide | CHEMBL1093698 | ||
Type | Small organic molecule | ||
Emp. Form. | C19H26F2N2O2 | ||
Mol. Mass. | 352.4187 | ||
SMILES | C[C@H]1CC[C@H](CC1)Oc1c(F)cc(CNC(=O)[C@@H]2CCCN2)cc1F |r,wU:17.17,wD:4.7,1.0,(-10.94,-38.56,;-9.61,-39.33,;-9.61,-40.88,;-8.28,-41.66,;-6.95,-40.88,;-6.94,-39.34,;-8.27,-38.57,;-5.62,-41.65,;-4.28,-40.88,;-4.28,-39.34,;-5.61,-38.57,;-2.95,-38.57,;-1.62,-39.33,;-.29,-38.56,;1.05,-39.32,;2.38,-38.55,;2.38,-37.01,;3.72,-39.31,;3.68,-40.85,;5.13,-41.37,;6.07,-40.15,;5.2,-38.88,;-1.61,-40.88,;-2.95,-41.66,;-2.95,-43.2,)| | ||
Structure |